In addition, we integrated the data of NMT1 and VILIP3 expression from Figs. 2e and 4j, and found that HCC patients with simultaneously higher expression of NMT1 and VILIP3 had poorer overall survival than patients with lower expression of both (Fig. 4k). The gene discussed is NMT1; the disease is hepatocellular carcinoma.